• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Drugs That Inhibit Malaria Infection and Block Transmission

Victor Nussenzweig of the New York University School of Medicine in the U.S. seeks to develop a small molecule drugs to inhibit key kinase enzymes in the malaria parasite that are thought to control latency in parasite infections. Such fundamental knowledge may enable new tools to clear the latent forms of P. vivax parasites or block transmission of the disease by targeting sporozoites.

More information about Create New Tools to Accelerate the Eradication of Malaria (Round 3)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.